Management of acute metastatic melanoma

How should we handle talimogene laherparepvec (T-VEC)?

New challenges in drug combination and strategies

Targeting N-RAS mutated tumours

HVEM expression in melanoma metastasis: prognosis correlation

Vemurafenib in patients with BRAF600 mutation–positive metastatic melanoma

Cancer and the workplace

Preventing cancer in the EU through legislation, education and taxation

Obesity and tobacco use increasing global cancer burden

Lessening the global financial burden of cancer

Research reproducibility and scientific ecosystems

Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous niche